BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28677753)

  • 21. A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.
    Ngan ES; Lang BH; Liu T; Shum CK; So MT; Lau DK; Leon TY; Cherny SS; Tsai SY; Lo CY; Khoo US; Tam PK; Garcia-Barceló MM
    J Natl Cancer Inst; 2009 Feb; 101(3):162-75. PubMed ID: 19176457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated analysis identifies DUSP5 as a novel prognostic indicator for thyroid follicular carcinoma.
    Zhang Q; Xing Y; Jiang S; Xu C; Zhou X; Zhang R; Xie T; Zou Z; Gong P; Zhu H; Zhang D; Ma H; Liao L; Dong J
    Thorac Cancer; 2020 Feb; 11(2):336-345. PubMed ID: 31821724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of expression of cell cycle/apoptosis genes along the spectrum of thyroid carcinoma progression.
    Saltman B; Singh B; Hedvat CV; Wreesmann VB; Ghossein R
    Surgery; 2006 Dec; 140(6):899-905; discussion 905-6. PubMed ID: 17188136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer.
    Li D; Jian W; Wei C; Song H; Gu Y; Luo Y; Fang L
    Int J Clin Exp Pathol; 2014; 7(11):7672-80. PubMed ID: 25550803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of CCNE2 protein and mRNA expression in thyroid cancer tissues.
    Liu CZ; Guo WP; Peng JB; Chen G; Lin P; Huang XL; Liu XF; Yang H; He Y; Pang YY; Ma W
    Adv Med Sci; 2020 Sep; 65(2):442-456. PubMed ID: 33059229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
    Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
    Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D receptor knockdown attenuates the antiproliferative, pro‑apoptotic and anti‑invasive effect of vitamin D by activating the Wnt/β‑catenin signaling pathway in papillary thyroid cancer.
    Pang R; Xu Y; Hu X; Liu B; Yu J
    Mol Med Rep; 2020 Nov; 22(5):4135-4142. PubMed ID: 33000217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activated E2F activity induces cell death in papillary thyroid carcinoma K1 cells with enhanced Wnt signaling.
    Yang D; Wang C; Luo Y; Li X; Song Q; Zhang J; Xin S
    PLoS One; 2017; 12(6):e0178908. PubMed ID: 28570681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of mucin-l and beta-catenin in papillary thyroid carcinoma and the clinical significance thereof].
    He F; Li H; Li WS; Dong XH
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):393-6. PubMed ID: 19567117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of β-catenin pathway.
    Bi W; Huang J; Nie C; Liu B; He G; Han J; Pang R; Ding Z; Xu J; Zhang J
    J Exp Clin Cancer Res; 2018 Nov; 37(1):275. PubMed ID: 30424816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNAs target the Wnt/β‑catenin signaling pathway to regulate epithelial‑mesenchymal transition in cancer (Review).
    Lei Y; Chen L; Zhang G; Shan A; Ye C; Liang B; Sun J; Liao X; Zhu C; Chen Y; Wang J; Zhang E; Deng L
    Oncol Rep; 2020 Oct; 44(4):1299-1313. PubMed ID: 32700744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of WD Repeat Domain 5 (WDR5) is Associated with Progression and Reduced Prognosis in Papillary Thyroid Carcinoma.
    Xu W; Wang L; An Y; Ye J
    Med Sci Monit; 2019 May; 25():3762-3770. PubMed ID: 31107859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Wnt/β-catenin signaling, stem-cell markers and proliferating cell markers in rat whisker hair follicles.
    Lin CM; Yuan YP; Chen XC; Li HH; Cai BZ; Liu Y; Zhang H; Li Y; Huang K
    J Mol Histol; 2015 Jun; 46(3):233-40. PubMed ID: 25832347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
    Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
    Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
    Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the expression and potential molecular mechanism of interleukin-1 receptor antagonist (IL1RN) in papillary thyroid cancer via bioinformatics methods.
    Xie Z; Li X; He Y; Wu S; Wang S; Sun J; He Y; Lun Y; Xin S; Zhang J
    BMC Cancer; 2020 Nov; 20(1):1143. PubMed ID: 33238942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulation of Wnt10a by RNA interference inhibits proliferation and promotes apoptosis in mouse embryonic palatal mesenchymal cells through Wnt/β-catenin signaling pathway.
    Feng C; Xu Z; Li Z; Zhang D; Liu Q; Lu L
    J Physiol Biochem; 2013 Dec; 69(4):855-63. PubMed ID: 23712503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of NOTCH-regulated Ankyrin Repeat Protein is associated with papillary thyroid carcinoma progression.
    Zhang M; Qin Y; Zuo B; Gong W; Zhang S; Gong Y; Quan Z; Chu B
    PLoS One; 2017; 12(2):e0167782. PubMed ID: 28207739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Evaluation of β-Catenin and E-Cadherin Expression in Liquid Aspiration Biopsy Specimens of Thyroid Nodules.
    Isaeva AV; Zima AP; Saprina TV; Kasoyan KT; Popov OS; Brynova OV; Berezkina IS; Vasil'eva OA; Ryazantseva NV; Shabalova IP; Litvinova LS; Pak YD; Novitskii VV
    Bull Exp Biol Med; 2016 Jun; 161(2):288-91. PubMed ID: 27383156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
    Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
    Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.